Department of Otolaryngology-Head and Neck Surgery, The Catholic University of Korea, College of Medicine, St Mary's Hospital, Bucheon, South Korea.
Otolaryngol Head Neck Surg. 2013 Aug;149(2):326-34. doi: 10.1177/0194599813490892. Epub 2013 May 28.
Adenotonsillar hypertrophy is considered the most common cause of pediatric obstructive sleep apnea syndrome (OSAS). This study aimed to evaluate the relationships between tonsil/adenoid size, parameters of polysomnography, and subjective sleep symptoms.
Case-control studies.
Tertiary care center.
A 4-point tonsil grading method and adenoid-nasopharynx (AN) ratio were used to categorize tonsil and adenoid size, respectively. Sleep questionnaires (Korean version of the Obstructive Sleep Apnea-18 [KOSA-18]) and full-attended polysomnography were performed.
The subjects (n = 70) were divided into a control group (n = 31, apnea-hypopnea index [AHI] <1) and an OSAS group (n = 39, AHI ≥ 1), which was subdivided into mild and moderate to severe groups. Tonsil/adenoid size showed a statistically significant difference between control and OSAS groups, but these differences had no clinical significance. In addition, tonsil/adenoid size did not differ significantly among 2 OSAS severity subgroups. Only adenoid size in the total and OSAS groups was related to quality of life (QOL) by the KOSA-18. The AN ratio was related to lowest oxygen saturation only in the OSAS group, especially in the moderate to severe OSAS group, but tonsil size was related to flow limitation in total and supine positions in the control group. In the control group, flow limitation was not associated with QOL.
Tonsil/adenoid size did not predict the severity of AHI. Nevertheless, adenoid size might be related to lowest oxygen saturation, which is thought to be related to subjective symptoms. Although flow limitation was related to tonsil size but not to QOL in the control group, further research will be needed to understand the importance of flow limitation and upper airway resistance syndrome in the pediatric population.
腺样体扁桃体肥大被认为是小儿阻塞性睡眠呼吸暂停综合征(OSAS)最常见的原因。本研究旨在评估扁桃体/腺样体大小、多导睡眠图参数与主观睡眠症状之间的关系。
病例对照研究。
三级保健中心。
采用 4 分法扁桃体分级和腺样体-鼻咽(AN)比值分别对扁桃体和腺样体大小进行分类。进行睡眠问卷(韩文版阻塞性睡眠呼吸暂停-18 项[KOSA-18])和全夜多导睡眠监测。
受试者(n = 70)分为对照组(n = 31,呼吸暂停低通气指数[AHI] < 1)和 OSAS 组(n = 39,AHI ≥ 1),后者又分为轻度和中重度。对照组和 OSAS 组之间的扁桃体/腺样体大小存在统计学差异,但无临床意义。此外,2 个 OSAS 严重程度亚组之间的扁桃体/腺样体大小无显著差异。仅总 OSAS 组的腺样体大小与 KOSA-18 的生活质量(QOL)相关。AN 比值仅在 OSAS 组与最低血氧饱和度相关,尤其是在中重度 OSAS 组,但在对照组中,扁桃体大小与总位和仰卧位的气流受限相关。在对照组中,气流受限与 QOL 无关。
扁桃体/腺样体大小不能预测 AHI 的严重程度。尽管如此,腺样体大小可能与最低血氧饱和度有关,而后者被认为与主观症状有关。虽然在对照组中,气流受限与扁桃体大小相关,但与 QOL 无关,但需要进一步研究以了解在儿科人群中气流受限和上气道阻力综合征的重要性。